Vasc Spec Int.  2015 Mar;31(1):20-24. 10.5758/vsi.2015.31.1.20.

On Postoperative Day Balloon Angioplasty for Salvage of Newly-Placed, Flow-Limiting Native Arteriovenous Fistula

Affiliations
  • 1Busan Vascular Clinic, Busan, Korea. microsurgical@yahoo.com

Abstract

PURPOSE
To report result and usefulness of immediate postoperative balloon angioplasty of de novo arteriovenous fistula (AVF) with limited flow just after creation.
MATERIALS AND METHODS
From January 1, 2012 to March 31, 2014, 1,270 patients received native AVF creations in a single vascular clinic. In twenty-four patients (1.9% of total AVF creation), immediate postoperative balloon angioplasty was performed because of limited flow on palpation (only pulsation or no thrill) just after AVF creation. Medical records were reviewed retrospectively; technical success (restoration of AVF flow)/clinical success (growing as functional AVF) rate, maturation time, primary patency rate and fistula survival outcome were analyzed during a mean 10.8 months of follow-up.
RESULTS
Technical/clinical success rate was 95.8% (23/24 cases); AVF flow was restored after balloon angioplasty, and all the flow-restorated AVFs grew as functional AVFs with mean+/-standard deviation, 4.5+/-1.5 weeks of maturation time. In seven (30.4%) patients, a secondary balloon angioplasty was needed to enhance maturation. The overall primary patency after immediate postoperative balloon angioplasty was 69.6% at 1 and 6 months and 59.0% at 12 months. There was 1 complication (operation site hematoma).
CONCLUSION
Immediate postoperative balloon angioplasty for salvage of newly-placed, flow-limiting native AVF is a useful, effective and safe procedure.

Keyword

Arteriovenous fistula; Angioplasty; Vascular patency

MeSH Terms

Angioplasty
Angioplasty, Balloon*
Arteriovenous Fistula*
Fistula
Follow-Up Studies
Humans
Medical Records
Palpation
Retrospective Studies
Vascular Patency
Full Text Links
  • VSI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr